Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 718 of 1,261

  1. US 9211315

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  2. US 9211302

    Modulation of LRCH4 activity and therapeutic application thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  3. US 9211289

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  4. US 9211277

    Dietary supplement composition

    YOUNG LIVING ESSENTIAL OILS, LC · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  5. US 9211275

    Ketone bodies and ketone body esters as blood lipid lowering agents

    The United States of America, as represented by the Secretary of the Department of Health and Human Services (DHSS) · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  6. US 9211244

    Method for anti-skin aging using caffeamide derivative

    China Medical University · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  7. US 9212218

    Vmp-like sequences of pathogenic Borrelia

    The Board of Regents of the University of Texas System · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  8. US 9210925

    Multipotent postnatal stem cells from human periodontal ligament and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  9. US 9212364

    Compositions and methods for inhibiting expression of mutant EGFR gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  10. US 9212168

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  11. US 9211419

    Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy

    The Board of Regents of the University of Texas System · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  12. US 9212129

    Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide

    VANDA PHARMACEUTICALS INC. · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  13. US 9212147

    Dihydroxy aromatic heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  14. US 9212212

    Targeting complement factor H for treatment of diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted

  15. WO 2015187736

    FORMULATIONS PLACEBO ET UTILISATIONS DE CELLES-CI

    ALLERGEN RES CORP [US] · Granted Dec 10, 2015 · Expires Dec 5, 2035

    granted

  16. EP 2952200

    Allergen zur vorbeugenden Behandlung von Allergien

    ALK ABELLÓ AS [DK] · Granted Dec 9, 2015 · Expires Dec 4, 2035

    granted

  17. US 9205131

    Use of IL-17D for the treatment and prevention of cancers

    The Regents of the University of California · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  18. US 9206159

    Piperazine-piperidine compounds as hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  19. US 9205048

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  20. US 9205088

    Compositions of 1,2,4-oxadiazol benzoic acid compounds and methods for their use

    PTC THERAPEUTICS, INC. · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  21. US 9206183

    Substituted pyrazolo[1,5-a]pyridines as JAK inhibitors

    Almirall, S.A. · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  22. US 9207243

    Use of GLUT4 inhibitors and DNA damaging agents for treating multiple myeloma

    Northwestern University · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  23. US 9205276

    Light as a replacement for mitogenic factors on progenitor cells

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND SERVICES · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

  24. US 9205119

    Neuroprotective compositions and methods

    The Regents of the University of California · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.